Risk of sarcopenia after bariatric surgery in patients with type 2 diabetes mellitus
Introduction. Despite the great popularity of Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy in the treatment of morbid obesity, the problem of the development and progression of sarcopenia in patients with type 2 diabetes mellitus in the postoperative period remains insufficiently stu...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LTD
2022-11-01
|
| Series: | Амбулаторная хирургия |
| Subjects: | |
| Online Access: | https://www.a-surgeon.ru/jour/article/view/319 |
| _version_ | 1826572367061581824 |
|---|---|
| author | A. G. Khitaryan A. A. Abovyan A. V. Mezhunts A. A. Orekhov D. A. Melnikov А. V. Sarkisyan S. A. Adizov A. A. Rogut G. J. Ziegler C. M.J. Amegninou |
| author_facet | A. G. Khitaryan A. A. Abovyan A. V. Mezhunts A. A. Orekhov D. A. Melnikov А. V. Sarkisyan S. A. Adizov A. A. Rogut G. J. Ziegler C. M.J. Amegninou |
| author_sort | A. G. Khitaryan |
| collection | DOAJ |
| description | Introduction. Despite the great popularity of Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy in the treatment of morbid obesity, the problem of the development and progression of sarcopenia in patients with type 2 diabetes mellitus in the postoperative period remains insufficiently studied.Aim. To study the prevalence and dynamics of sarcopenia in patients with type 2 diabetes mellitus after Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy in the long term.Materials and methods. Our prospective study included 257 bariatric patients (170 Roux-en-Y gastric bypass and 87 laparoscopic sleeve gastrectomy) with type 2 diabetes mellitus. All patients underwent a standard set of preoperative examination with obligatory determination of the skeletal muscle mass index using the bioelectrical impedance analysis. After 6, 12, 18 and 24 months, control examinations were carried out.Results. At the preoperative stage, 28 patients (16.5%) with signs of moderate sarcopenia were identified in the Roux-en-Y gastric bypass group and 15 patients (17.2%) in the laparoscopic sleeve gastrectomy group. According to the bioelectrical impedance analysis, 24 months after the operation, 37 patients (25.9%) with signs of moderate sarcopenia and 2 patients (1.4%) with severe sarcopenia were identified in the first group. 24 months after surgery in the second group there was no statistical difference in the number of patients with signs of sarcopenia in comparison with the preoperative period.Conclusion. The frequency of development and progression of signs of sarcopenia after Roux-en-Y gastric bypass is statistically higher than after laparoscopic sleeve gastrectomy. In this regard, in our opinion, when choosing a method of surgical treatment of morbid obesity with concomitant type 2 diabetes mellitus, a detailed assessment of the state of protein metabolism by the bioelectrical impedance analysis is necessary. |
| first_indexed | 2024-04-10T04:00:17Z |
| format | Article |
| id | doaj.art-33a176eed72349358b16e4753edb927f |
| institution | Directory Open Access Journal |
| issn | 2712-8741 2782-2591 |
| language | Russian |
| last_indexed | 2025-03-14T12:25:53Z |
| publishDate | 2022-11-01 |
| publisher | Remedium Group LTD |
| record_format | Article |
| series | Амбулаторная хирургия |
| spelling | doaj.art-33a176eed72349358b16e4753edb927f2025-03-02T09:28:57ZrusRemedium Group LTDАмбулаторная хирургия2712-87412782-25912022-11-0119214215110.21518/1995-1477-2022-19-2-142-151278Risk of sarcopenia after bariatric surgery in patients with type 2 diabetes mellitusA. G. Khitaryan0A. A. Abovyan1A. V. Mezhunts2A. A. Orekhov3D. A. Melnikov4А. V. Sarkisyan5S. A. Adizov6A. A. Rogut7G. J. Ziegler8C. M.J. Amegninou9Clinical Hospital Russian Railway-Medicine Rostov-on-Don; Rostov State Medical UniversityRostov State Medical UniversityClinical Hospital Russian Railway-Medicine Rostov-on-Don; Rostov State Medical UniversityRostov State Medical UniversityClinical Hospital Russian Railway-Medicine Rostov-on-Don; Rostov State Medical UniversityRostov State Medical UniversityClinical Hospital Russian Railway-Medicine Rostov-on-DonClinical Hospital Russian Railway-Medicine Rostov-on-DonRostov State Medical UniversityRostov State Medical UniversityIntroduction. Despite the great popularity of Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy in the treatment of morbid obesity, the problem of the development and progression of sarcopenia in patients with type 2 diabetes mellitus in the postoperative period remains insufficiently studied.Aim. To study the prevalence and dynamics of sarcopenia in patients with type 2 diabetes mellitus after Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy in the long term.Materials and methods. Our prospective study included 257 bariatric patients (170 Roux-en-Y gastric bypass and 87 laparoscopic sleeve gastrectomy) with type 2 diabetes mellitus. All patients underwent a standard set of preoperative examination with obligatory determination of the skeletal muscle mass index using the bioelectrical impedance analysis. After 6, 12, 18 and 24 months, control examinations were carried out.Results. At the preoperative stage, 28 patients (16.5%) with signs of moderate sarcopenia were identified in the Roux-en-Y gastric bypass group and 15 patients (17.2%) in the laparoscopic sleeve gastrectomy group. According to the bioelectrical impedance analysis, 24 months after the operation, 37 patients (25.9%) with signs of moderate sarcopenia and 2 patients (1.4%) with severe sarcopenia were identified in the first group. 24 months after surgery in the second group there was no statistical difference in the number of patients with signs of sarcopenia in comparison with the preoperative period.Conclusion. The frequency of development and progression of signs of sarcopenia after Roux-en-Y gastric bypass is statistically higher than after laparoscopic sleeve gastrectomy. In this regard, in our opinion, when choosing a method of surgical treatment of morbid obesity with concomitant type 2 diabetes mellitus, a detailed assessment of the state of protein metabolism by the bioelectrical impedance analysis is necessary.https://www.a-surgeon.ru/jour/article/view/319obesitybariatric surgerytype 2 diabetes mellitussarcopeniabioelectrical impedance analysis |
| spellingShingle | A. G. Khitaryan A. A. Abovyan A. V. Mezhunts A. A. Orekhov D. A. Melnikov А. V. Sarkisyan S. A. Adizov A. A. Rogut G. J. Ziegler C. M.J. Amegninou Risk of sarcopenia after bariatric surgery in patients with type 2 diabetes mellitus Амбулаторная хирургия obesity bariatric surgery type 2 diabetes mellitus sarcopenia bioelectrical impedance analysis |
| title | Risk of sarcopenia after bariatric surgery in patients with type 2 diabetes mellitus |
| title_full | Risk of sarcopenia after bariatric surgery in patients with type 2 diabetes mellitus |
| title_fullStr | Risk of sarcopenia after bariatric surgery in patients with type 2 diabetes mellitus |
| title_full_unstemmed | Risk of sarcopenia after bariatric surgery in patients with type 2 diabetes mellitus |
| title_short | Risk of sarcopenia after bariatric surgery in patients with type 2 diabetes mellitus |
| title_sort | risk of sarcopenia after bariatric surgery in patients with type 2 diabetes mellitus |
| topic | obesity bariatric surgery type 2 diabetes mellitus sarcopenia bioelectrical impedance analysis |
| url | https://www.a-surgeon.ru/jour/article/view/319 |
| work_keys_str_mv | AT agkhitaryan riskofsarcopeniaafterbariatricsurgeryinpatientswithtype2diabetesmellitus AT aaabovyan riskofsarcopeniaafterbariatricsurgeryinpatientswithtype2diabetesmellitus AT avmezhunts riskofsarcopeniaafterbariatricsurgeryinpatientswithtype2diabetesmellitus AT aaorekhov riskofsarcopeniaafterbariatricsurgeryinpatientswithtype2diabetesmellitus AT damelnikov riskofsarcopeniaafterbariatricsurgeryinpatientswithtype2diabetesmellitus AT avsarkisyan riskofsarcopeniaafterbariatricsurgeryinpatientswithtype2diabetesmellitus AT saadizov riskofsarcopeniaafterbariatricsurgeryinpatientswithtype2diabetesmellitus AT aarogut riskofsarcopeniaafterbariatricsurgeryinpatientswithtype2diabetesmellitus AT gjziegler riskofsarcopeniaafterbariatricsurgeryinpatientswithtype2diabetesmellitus AT cmjamegninou riskofsarcopeniaafterbariatricsurgeryinpatientswithtype2diabetesmellitus |